- Home
- SBFM vs EVOK Comparison
SBFM vs EVOK Comparison
Compare SBFM & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- EVOK
- Stock Information
- Founded
- SBFM 2006
- EVOK 2007
- Country
- SBFM United States
- EVOK United States
- Employees
- SBFM N/A
- EVOK N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- SBFM Health Care
- EVOK Health Care
- Exchange
- SBFM Nasdaq
- EVOK Nasdaq
- Market Cap
- SBFM 3.7M
- EVOK 4.3M
- IPO Year
- SBFM N/A
- EVOK 2013
- Fundamental
- Price
- SBFM $2.35
- EVOK $4.58
- Analyst Decision
- SBFM
- EVOK
- Analyst Count
- SBFM 0
- EVOK 0
- Target Price
- SBFM N/A
- EVOK N/A
- AVG Volume (30 Days)
- SBFM 151.4K
- EVOK 1.2M
- Earning Date
- SBFM 11-05-2024
- EVOK 11-07-2024
- Dividend Yield
- SBFM N/A
- EVOK N/A
- EPS Growth
- SBFM N/A
- EVOK N/A
- EPS
- SBFM N/A
- EVOK N/A
- Revenue
- SBFM $32,959,491.00
- EVOK $8,617,036.00
- Revenue This Year
- SBFM $86.70
- EVOK $124.10
- Revenue Next Year
- SBFM $126.76
- EVOK $75.70
- P/E Ratio
- SBFM N/A
- EVOK N/A
- Revenue Growth
- SBFM 61.94
- EVOK 100.35
- 52 Week Low
- SBFM $2.25
- EVOK $3.54
- 52 Week High
- SBFM $638.00
- EVOK $17.40
- Technical
- Relative Strength Index (RSI)
- SBFM 25.54
- EVOK 39.65
- Support Level
- SBFM $2.58
- EVOK $4.03
- Resistance Level
- SBFM $2.86
- EVOK $6.09
- Average True Range (ATR)
- SBFM 0.17
- EVOK 0.58
- MACD
- SBFM -0.04
- EVOK -0.20
- Stochastic Oscillator
- SBFM 12.67
- EVOK 20.52
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.